Effects of a High-intensity Interval Strength Training Programme in Institutionalized Older Adults With Sarcopenia: a Randomized Clinical Trial.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 164
- 试验地点
- 1
- 主要终点
- Hand grip strenght
研究概览
简要总结
Sarcopenia is one of the main problems in the elderly population. The concept of disease has evolved, as have its treatment strategies. Among these is high-intensity interval training (HIIT). This approach has been little studied in older adults with sarcopenia, especially in institutionalized older adults in nursing homes. So this will be the objective of the study. A randomised clinical trial is being conducted to analyse how these diagnostic criteria for sarcopenia evolve after the application of HIIT compared to a control group.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •older adults who have been institutionalized for at least one year
- •older adults who are institutionalized with clinical suspicion of sarcopenia according to the Sarc-F questionnaire and muscle strength criteria
- •older adults residing in the community of Extremadura.
排除标准
- •present cognitive impairment (score <24 Mini-Mental State Examination)
- •primary, serious, or chronic diseases that could explain the decrease in muscle strength and the other diagnostic variables of the participants
- •diseases or physical disorders that hinder the assessment of the participants; -use of drugs that may affect muscle strength and mass.
研究组 & 干预措施
This group includes institutionalized older adults aged 60 and over for treatment.
干预措施: High-intensity interval strength training: therapeutic exercise programme. (Other)
This group includes institutionalized older adults aged 60 and over.
结局指标
主要结局
Hand grip strenght
时间窗: Thrice at the baseline: at the start, at 8 weeks and at 12 weeks.
The researchers used the JAMAR dynamometer
次要结局
- Muscular mass / appendicular skeletal mass (ASM)(Thrice at the baseline: at the start, at 8 weeks and at 12 weeks.)
- Physical performance(Thrice at the baseline: at the start, at 8 weeks and at 12 weeks.)
- Physical performance 2(Thrice at the baseline: at the start, at 8 weeks and at 12 weeks.)
研究者
Jesús Zapata Linares
Clinical professor
University of Extremadura